ICD-10 Coding for Polycythemia(D47.1U, D75.0, D75.1)
Explore detailed ICD-10 coding for polycythemia, including polycythemia vera and secondary polycythemia. Learn about JAK2 mutation testing and documentation requirements.
Complete code families applicable to Polycythemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D45 | Polycythemia vera | Use when polycythemia vera is confirmed by clinical and laboratory findings. |
|
| D75.1 | Secondary polycythemia | Use when polycythemia is secondary to another condition such as hypoxia or tumors. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPolycythemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Polycythemia.
Omitting JAK2 mutation status
Impact
Clinical: Misdiagnosis of polycythemia type., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect billing and reimbursement.
Mitigation
Ensure JAK2 testing is part of diagnostic workup., Include mutation status in documentation.
Coding D45 without JAK2 confirmation
Impact
Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure JAK2 testing is documented before coding D45.
Polycythemia coding accuracy
Impact
Risk of incorrect coding due to lack of specific documentation.
Mitigation
Implement thorough documentation practices and regular audits.